Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
Research ArticleClinical Studies

Dynamic Contrast-enhanced Magnetic Resonance Imaging in the Early Evaluation of Anti-angiogenic Therapy in Metastatic Renal Cell Carcinoma

VALERIA PANEBIANCO, ROBERTO IACOVELLI, FLAVIO BARCHETTI, AMELIA ALTAVILLA, VALERIO FORTE, ALESSANDRO SCIARRA, ENRICO CORTESI and CARLO CATALANO
Anticancer Research December 2013, 33 (12) 5663-5666;
VALERIA PANEBIANCO
1Radiological Unit, Department of Radiological Sciences, Oncology and Pathology, Sapienza, University of Rome, Rome, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: valeria.panebianco@gmail.com
ROBERTO IACOVELLI
2Oncological Unit, Department of Radiological Sciences, Oncology and Pathology, Sapienza, University of Rome, Rome, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
FLAVIO BARCHETTI
1Radiological Unit, Department of Radiological Sciences, Oncology and Pathology, Sapienza, University of Rome, Rome, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
AMELIA ALTAVILLA
2Oncological Unit, Department of Radiological Sciences, Oncology and Pathology, Sapienza, University of Rome, Rome, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
VALERIO FORTE
1Radiological Unit, Department of Radiological Sciences, Oncology and Pathology, Sapienza, University of Rome, Rome, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
ALESSANDRO SCIARRA
3Department of Urology, Sapienza, University of Rome, Rome, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
ENRICO CORTESI
2Oncological Unit, Department of Radiological Sciences, Oncology and Pathology, Sapienza, University of Rome, Rome, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
CARLO CATALANO
1Radiological Unit, Department of Radiological Sciences, Oncology and Pathology, Sapienza, University of Rome, Rome, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • Figure 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 1.

    MRI of a female patient showing a metastatic lesion in the VII-VIII segment before treatment (a-c) and after four weeks of treatment (d-f). a: T2-weighted sequences show a inhomogeneous hyperintense mass of 4 cm in maximum diameter. b: Qualitative assessment of perfusion images show the same lesion as a hypointense zone with peripheral vascularization; regions of interest were plotted on the lesion, abdominal aorta, liver and muscle. c: Semi-quantitave analysis using intensity/time curves highlights the grade of vascularization of the lesion. d: T2-weighted sequences showing a slight dimensional reduction of approximately 0.5 cm of the metastatic lesion after four weeks of treatment. e: Qualitative assessment using perfusion images depicting the reduction of vascularization of the lesion; regions of interest were plotted on the metastasis, aorta, liver and muscle. f: Semi-quantitative approach revealing the lesion's behavior compared to the aorta, liver and muscle. The semi-quantitave analysis by means of intensity/time curves adds important functional information to morphological criteria, which only indicates dimensional reduction; the former highlights the reduction of neoangiogenesis and therefore the response to anti-angiogenic therapy.

Tables

  • Figures
  • Table I.
PreviousNext
Back to top

In this issue

Anticancer Research: 33 (12)
Anticancer Research
Vol. 33, Issue 12
December 2013
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Dynamic Contrast-enhanced Magnetic Resonance Imaging in the Early Evaluation of Anti-angiogenic Therapy in Metastatic Renal Cell Carcinoma
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
7 + 3 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Dynamic Contrast-enhanced Magnetic Resonance Imaging in the Early Evaluation of Anti-angiogenic Therapy in Metastatic Renal Cell Carcinoma
VALERIA PANEBIANCO, ROBERTO IACOVELLI, FLAVIO BARCHETTI, AMELIA ALTAVILLA, VALERIO FORTE, ALESSANDRO SCIARRA, ENRICO CORTESI, CARLO CATALANO
Anticancer Research Dec 2013, 33 (12) 5663-5666;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Dynamic Contrast-enhanced Magnetic Resonance Imaging in the Early Evaluation of Anti-angiogenic Therapy in Metastatic Renal Cell Carcinoma
VALERIA PANEBIANCO, ROBERTO IACOVELLI, FLAVIO BARCHETTI, AMELIA ALTAVILLA, VALERIO FORTE, ALESSANDRO SCIARRA, ENRICO CORTESI, CARLO CATALANO
Anticancer Research Dec 2013, 33 (12) 5663-5666;
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Patients and Methods
    • Results
    • Discussion
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • Estimation of the Six-month Survival Probability After Radiosurgery for Brain Metastases from Kidney Cancer
  • Google Scholar

More in this TOC Section

  • The Systemic Inflammation Score Is an Independent Prognostic Factor for Esophageal Cancer Patients who Receive Curative Treatment
  • Impact of Cytoreductive Nephrectomy Following Nivolumab Plus Ipilimumab Therapy for Patients With Advanced Renal Cell Carcinoma
  • Usefulness of Prophylactic Administration of Pegfilgrastim for Esophageal Cancer Chemotherapy: A Single-center Retrospective Study
Show more Clinical Studies

Similar Articles

Keywords

  • Metastatic renal cell carcinoma
  • targeted therapies
  • angiogenesis
  • MRI
  • peak enhancement
Anticancer Research

© 2022 Anticancer Research

Powered by HighWire